Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 422 of 6351
-
New drug masitinib could slow Alzheimer's decline
Disease control Not yet recruitingMasitinib is an orally administered tyrosine kinase inhibitor that targets activated cells of the neuroimmune system (mast cells and microglia). Study AB21004 will evaluate masitinib as an adjunct to cholinesterase inhibitor and/or memantine in patients with mild-to-moderate Alzh…
Phase 3 • Sponsor: AB Science • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New bone filler aims to stop stubborn bone infections without extra surgery
Disease control Recruiting nowThe purpose of this trial is to determine if genex with gentamicin (genex G) an antibiotic loaded bone void filler, works to treat and is a safe option as part of the surgical treatment of osteomyelitis in the extremities.
Sponsor: Biocomposites Ltd • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Vulvar cancer study aims to spare women from unnecessary surgery
Disease control Not yet recruitingThis study is a phase III, open label, multicentre, three-group, randomised clinical trial. The primary aim of this study is to determine whether intensive groin ultrasound monitoring (1) is effective and safe to replace invasive groin lymph node dissection (LND) to manage vulvar…
Phase 3 • Sponsor: Queensland Centre for Gynaecological Cancer • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New lung device aims to calm COPD symptoms
Disease control Not yet recruitingThe goal of this study is to test whether a new treatment called the Ryme Medical Targeted Lung Denervation (TLD) Catheter is safe and effective for people with moderate to severe chronic obstructive pulmonary disease (COPD). The main questions it aims to answer are: 1. Does th…
Sponsor: Ryme Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
One-Time gene shot aims to mend broken hearts
Disease control Recruiting nowThis is a Phase 1, open-label, dose-escalation trial to characterize the safety, tolerability, and preliminary efficacy of RP-A701 following a single IV administration in high-risk adult patients with BAG3-DCM.
Phase 1 • Sponsor: Rocket Pharmaceuticals Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Sound waves and immunotherapy join forces against deadly brain tumor
Disease control Not yet recruitingNavigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma with Mismatch Repair Deficiency.
Phase 1 • Sponsor: Jennifer Leddon • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug cocktail aims to shrink liver tumors for surgery
Disease control Not yet recruitingThis study is a single-center, prospective, randomized, single-arm phase II clinical trial designed to evaluate the safety and efficacy of FULIRI chemotherapy regimen combined with targeted therapy (bevacizumab/cetuximab) as first-line conversion therapy for colorectal cancer wit…
Phase 2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug cocktail takes aim at tough lung cancer
Disease control Not yet recruitingThis is a Phase Ib/II, open-label clinical study designed to evaluate the safety, tolerability, preliminary anti-tumor activity, recommended Phase 2 dose (RP2D), pharmacokinetic (PK) characteristics, and immunogenicity of DXC006 in combination with an immune checkpoint inhibitor …
Phase 1/2 • Sponsor: Hangzhou DAC Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New model may predict and prevent deadly transplant complication
Disease control Not yet recruitingThis study aims to evaluate the efficacy of prophylactic ruxolitinib in adult patients at intermediate-to-high risk of severe acute GvHD, as predicted by the daGOAT model.
Phase 3 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immunotherapy plus chemo may open door to surgery for inoperable lung cancer
Disease control Not yet recruitingThis is a prospective, single-center phase II study evaluating sintilimab plus chemotherapy as induction therapy for unresectable stage IIIC non-small cell lung cancer (NSCLC). Treatment-naive eligible patients who signed informed consent were enrolled after MDT screening. Patien…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New drug targets hidden heart risk in people with high lp(a)
Disease control Recruiting nowLipoprotein(a), also known as Lp(a), is a protein that carries cholesterol and proteins in your blood. People with high Lp(a) have a higher risk for heart disease. The main purpose of the study is to investigate how lepodisiran, compared to a placebo, affects the amount and type …
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Rural doctor + telemedicine: a new way to cut stroke risk in seniors?
Disease control Recruiting nowThis cluster randomized controlled trial aims to evaluate the effectiveness of a novel telemedicine-enabled integrated care model led by rural doctors in reducing cardiovascular and cerebrovascular events among elderly adults (≥65 years) at high risk of stroke in rural China. A t…
Sponsor: Jiangsu Province (Suqian) Hospital • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New combo therapy aims to wipe out leukemia cells for good
Disease control Stopped earlyThe purpose of this study is to determine the feasibility, safety, and efficacy of a combination therapy in the treatment of B-cell acute lymphoblastic leukemia (B-ALL) based on multi-antigen-targeted chimeric antigen receptor T cells (CAR-T) followed by engineered immune effecto…
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Can a mix of diet, exercise, and brain games keep aging minds sharp?
Prevention Not yet recruitingCognitive impairment and dementia can cause considerable suffering, both for the person affected and for next of kin. They also pose major challenges for health and social care. At the same time, research shows that many risk factors for cognitive decline can, in fact, be influen…
Sponsor: University of Gavle • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Light-Based therapy may tame kidney transplant rejection
Disease control Recruiting nowThis study aims to describe, over a one-year period, the clinical, biological, and histological evolution of a cohort of kidney transplant recipients who developed antibody-mediated rejection and were treated with extracorporeal photopheresis.
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Glowing light could spot oral cancer before it starts
Prevention By invitation onlyPatients attending the Department of Oral Mucosal and Periodontal Diseases at the University Dental Center of the Medical University of Warsaw who provide written informed consent will be invited to participate in the study. Participation will begin with completing a short, anon…
Sponsor: Medical University of Warsaw • Aim: Prevention
Last updated Jul 08, 2026 00:00 UTC
-
Engineered immune cells take on incurable blood cancer
Disease control Recruiting nowThe treatment options for multiple myeloma have evolved significantly over the years, providing patients with a range of therapies tailored to their specific circumstances. The choice of treatment often hinges on various factors, including the aggressiveness of the disease, indiv…
Phase 2 • Sponsor: Dr. Zaineb Akram • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Metabolic MRI may reveal hidden cancer responses and spare patients from surgery
Knowledge-focused Recruiting nowThis study is testing new imaging and analysis methods to improve how doctors predict treatment response in rectal cancer patients receiving chemoradiotherapy. Current MRI scans sometimes miss complete tumor response, which can lead to unnecessary surgery. To address this, resear…
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Ear seeds and smart glasses: a new hope to halt childhood myopia?
Prevention Recruiting nowThis is a prospective, school-based randomized controlled trial designed to evaluate auricular acupressure combined with defocus spectacle lenses for myopia control in primary school students with premyopia or myopia. Enrolled students in grades 1 to 4 will be randomly assigned t…
Sponsor: Shanghai Eye Disease Prevention and Treatment Center • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Can a mineral ease severe headaches faster than standard painkillers?
Symptom relief Recruiting nowHeadache is one of the most common reasons for consultation in emergency departments and represents a significant cause of disability, particularly in patients with migraine and other primary headache disorders. Despite the availability of several analgesic treatments, including …
Sponsor: University of Monastir • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC